INOVOTION visit
INOVOTION is a biotech company (spin-off from Grenoble-Alpes University) which developed a unique in vivo technology dedicated to efficacy and toxicity evaluations for oncology and immuno-oncology treatments.
This unique platform provides early analysis of drug candidates from small molecules to
biologics, before the classical preclinical stage. By eliminating low-value molecules early,
INOVOTION accelerates the drug discovery process, increases the R&D productivity, and
reduces its costs.
INOVOTION built this xenograft model using chicken embryo because it has tremendous
benefits: fast, robust, affordable, and predictive. These in vivo assays will save time and give
a clear competitive advantage to public and private researchers.
This next generation of in vivo efficacy and toxicity tests covers fours main aspects:
- Efficacy assays for anti-cancer treatments including antibodies and immune-checkpoints
- Early Toxicity assays for drug candidates
- Target Validation in oncology
- Multi-Cancer Screening to (re)positioning a treatment
INOVOTION has been invited by prof.dr. Ronit Shiri-Sverdlov as part of the monthly Scientific Meeting with Division II within NUTRIM.
UNS50, level 5
Genetics & Cell BiologyRelevant links
Website: INOVOTION
Also read
-
27 Jun 31 Dec11:00 - 15:30
Globalization & Law Network Seminar Series 2023 - 2024
The Globalization & Law Network is composed by a group of researchers of Maastricht University, coming from different backgrounds, who study the role that law plays in a globalizing society from a holistic perspective. Invited experts will give a presentation on a specific topic followed by a Q&A...
-
28 Jun 06 Dec10:00 - 17:00
Graduation Ceremonies Masters
We are proud to hand the diploma's to our graduates on this festive day.
-
01 Jul 05 Jul
Summer School on Affective Neuroscience
The Summer School on Affective Neuroscience provides an education in the specialized field of affective neuroscience.